Cancer Research Meeting Calendar Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venables, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venables, J. P.
Related Collections
Right arrow Therapeutics and Targets
Right arrow Therapeutics and Targets: Identification, Validation, and Markers
[Cancer Research 64, 7647-7654, November 1, 2004]
© 2004 American Association for Cancer Research

Review

Aberrant and Alternative Splicing in Cancer

Julian P. Venables

University of Newcastle-upon-Tyne, Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle-upon-Tyne, United Kingdom

Pre-mRNA splicing is a sophisticated and ubiquitous nuclear process, which is a natural source of cancer-causing errors in gene expression. Intronic splice site mutations of tumor suppressor genes often cause exon-skipping events that truncate proteins just like classical nonsense mutations. Also, many studies over the last 20 years have reported cancer-specific alternative splicing in the absence of genomic mutations. Affected proteins include transcription factors, cell signal transducers, and components of the extracellular matrix. Antibodies against alternatively spliced products on cancer cells are currently in clinical trials, and competitive reverse transcription-PCR across regions of alternative splicing is being used as a simple diagnostic test. As well as being associated with cancer, the nature of the alternative gene products is usually consistent with an active role in cancer; therefore, the alternative splicing process itself is a potential target for gene therapy.




This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
S. M. Woerner, Y. P. Yuan, A. Benner, S. Korff, M. von Knebel Doeberitz, and P. Bork
SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology
Nucleic Acids Res., October 9, 2009; (2009) gkp839v1.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Belfiore, F. Frasca, G. Pandini, L. Sciacca, and R. Vigneri
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Endocr. Rev., October 1, 2009; 30(6): 586 - 623.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
V. Goncalves, P. Matos, and P. Jordan
Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways
Hum. Mol. Genet., October 1, 2009; 18(19): 3696 - 3707.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
H. C. Cheung, T. Hai, W. Zhu, K. A. Baggerly, S. Tsavachidis, R. Krahe, and G. J. Cote
Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines
Brain, August 1, 2009; 132(8): 2277 - 2288.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Korner and L. J. Miller
Alternative Splicing of Pre-mRNA in Cancer: Focus on G Protein-Coupled Peptide Hormone Receptors
Am. J. Pathol., August 1, 2009; 175(2): 461 - 472.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Ghosh, H. Kuppusamy, and L. M. Pilarski
Aberrant Splice Variants of HAS1 (Hyaluronan Synthase 1) Multimerize with and Modulate Normally Spliced HAS1 Protein: A POTENTIAL MECHANISM PROMOTING HUMAN CANCER
J. Biol. Chem., July 10, 2009; 284(28): 18840 - 18850.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X. Lu, X. Feng, X. Man, G. Yang, L. Tang, D. Du, F. Zhang, H. Yuan, Q. Huang, Z. Zhang, et al.
Aberrant Splicing of Hugl-1 Is Associated with Hepatocellular Carcinoma Progression
Clin. Cancer Res., May 15, 2009; 15(10): 3287 - 3296.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
L. Jiang, H.S. Yang, Z. Wang, Y. Zhou, M. Zhou, X. Zeng, and Q.M. Chen
ORAOV1-A Correlates with Poor Differentiation in Oral Cancer
Journal of Dental Research, May 1, 2009; 88(5): 433 - 438.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Hirschfeld, A. zur Hausen, H. Bettendorf, M. Jager, and E. Stickeler
Alternative Splicing of Cyr61 Is Regulated by Hypoxia and Significantly Changed in Breast Cancer
Cancer Res., March 1, 2009; 69(5): 2082 - 2090.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Adamia, A. A. Reichert, H. Kuppusamy, J. Kriangkum, A. Ghosh, J. J. Hodges, P. M. Pilarski, S. P. Treon, M. J. Mant, T. Reiman, et al.
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia
Blood, December 15, 2008; 112(13): 5111 - 5121.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
V. Goncalves, P. Matos, and P. Jordan
The {beta}-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression
RNA, December 1, 2008; 14(12): 2538 - 2549.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. P. Venables, R. Klinck, A. Bramard, L. Inkel, G. Dufresne-Martin, C. Koh, J. Gervais-Bird, E. Lapointe, U. Froehlich, M. Durand, et al.
Identification of Alternative Splicing Markers for Breast Cancer
Cancer Res., November 15, 2008; 68(22): 9525 - 9531.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
L. Xi, A. Feber, V. Gupta, M. Wu, A. D. Bergemann, R. J. Landreneau, V. R. Litle, A. Pennathur, J. D. Luketich, and T. E. Godfrey
Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer
Nucleic Acids Res., November 1, 2008; 36(20): 6535 - 6547.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
P. Gorello, L. Brandimarte, R. La Starza, V. Pierini, L. Bury, R. Rosati, M. F. Martelli, P. Vandenberghe, I. Wlodarska, and C. Mecucci
t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia
Haematologica, September 1, 2008; 93(9): 1398 - 1401.
[Abstract] [Full Text] [PDF]

Home page
 BioinformaticsHome page
E. Purdom, K. M. Simpson, M. D. Robinson, J. G. Conboy, A. V. Lapuk, and T.P. Speed
FIRMA: a method for detection of alternative splicing from exon array data
Bioinformatics, August 1, 2008; 24(15): 1707 - 1714.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
Y.-T. Huang, F.-C. Chen, C.-J. Chen, H.-L. Chen, and T.-J. Chuang
Identification and analysis of ancestral hominoid transcriptome inferred from cross-species transcript and processed pseudogene comparisons
Genome Res., July 1, 2008; 18(7): 1163 - 1170.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. P. O'Rourke and S. A. Ness
Alternative RNA Splicing Produces Multiple Forms of c-Myb with Unique Transcriptional Activities
Mol. Cell. Biol., March 15, 2008; 28(6): 2091 - 2101.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
F. Birzele, G. Csaba, and R. Zimmer
Alternative splicing and protein structure evolution
Nucleic Acids Res., February 2, 2008; 36(2): 550 - 558.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Klinck, A. Bramard, L. Inkel, G. Dufresne-Martin, J. Gervais-Bird, R. Madden, E. R. Paquet, C. Koh, J. P. Venables, P. Prinos, et al.
Multiple Alternative Splicing Markers for Ovarian Cancer
Cancer Res., February 1, 2008; 68(3): 657 - 663.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
G. Ohno, M. Hagiwara, and H. Kuroyanagi
STAR family RNA-binding protein ASD-2 regulates developmental switching of mutually exclusive alternative splicing in vivo
Genes & Dev., February 1, 2008; 22(3): 360 - 374.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Shi, Z. Hu, K. Pabon, and K. W. Scotto
Caffeine Regulates Alternative Splicing in a Subset of Cancer-Associated Genes: a Role for SC35
Mol. Cell. Biol., January 15, 2008; 28(2): 883 - 895.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
G. G. Leparc and R. D. Mitra
A sensitive procedure to detect alternatively spliced mRNA in pooled-tissue samples
Nucleic Acids Res., December 18, 2007; 35(21): e146 - e146.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. A. Schiel, S.-l. Green, W. I. Davis, P. C. Sanghani, W. F. Bosron, and S. P. Sanghani
Expression and Characterization of a Human Carboxylesterase 2 Splice Variant
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 94 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Filippov, M. Filippova, and P. J. Duerksen-Hughes
The Early Response to DNA Damage Can Lead to Activation of Alternative Splicing Activity Resulting in CD44 Splice Pattern Changes
Cancer Res., August 15, 2007; 67(16): 7621 - 7630.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
T. Moroy and F. Heyd
The impact of alternative splicing in vivo: Mouse models show the way
RNA, August 1, 2007; 13(8): 1155 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Izquierdo and J. Valcarcel
Two Isoforms of the T-cell Intracellular Antigen 1 (TIA-1) Splicing Factor Display Distinct Splicing Regulation Activities: CONTROL OF TIA-1 ISOFORM RATIO BY TIA-1-RELATED PROTEIN
J. Biol. Chem., July 6, 2007; 282(27): 19410 - 19417.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. E. Weigand and B. Suess
Tetracycline aptamer-controlled regulation of pre-mRNA splicing in yeast
Nucleic Acids Res., June 12, 2007; (2007) gkm425v1.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. J. Kim, J.-Y. Hwang, H. J. Kim, W. S. Choi, J. H. Lee, H. J. Kim, K. C. Chang, T. Nishinaka, C. Yabe-Nishimura, and H. G. Seo
Expression of a Peroxisome Proliferator-Activated Receptor {gamma}1 Splice Variant that Was Identified in Human Lung Cancers Suppresses Cell Death Induced by Cisplatin and Oxidative Stress
Clin. Cancer Res., May 1, 2007; 13(9): 2577 - 2583.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Di Modugno, L. DeMonte, M. Balsamo, G. Bronzi, M. R. Nicotra, M. Alessio, E. Jager, J. S. Condeelis, A. Santoni, P. G. Natali, et al.
Molecular Cloning of hMena (ENAH) and Its Splice Variant hMena+11a: Epidermal Growth Factor Increases Their Expression and Stimulates hMena+11a Phosphorylation in Breast Cancer Cell Lines
Cancer Res., March 15, 2007; 67(6): 2657 - 2665.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. M. Hayes, P. E. Carrigan, and L. J. Miller
Serine-Arginine Protein Kinase 1 Overexpression Is Associated with Tumorigenic Imbalance in Mitogen-Activated Protein Kinase Pathways in Breast, Colonic, and Pancreatic Carcinomas
Cancer Res., March 1, 2007; 67(5): 2072 - 2080.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Shinojima, M. Oya, A. Takayanagi, R. Mizuno, N. Shimizu, and M. Murai
Renal cancer cells lacking hypoxia inducible factor (HIF)-1{alpha} expression maintain vascular endothelial growth factor expression through HIF-2{alpha}
Carcinogenesis, March 1, 2007; 28(3): 529 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Yu, X. Jiang, B. S. Schoch, R. S. Carroll, P. M. Black, and M. D. Johnson
Aberrant Splicing of Cyclin-Dependent Kinase-Associated Protein Phosphatase KAP Increases Proliferation and Migration in Glioblastoma
Cancer Res., January 1, 2007; 67(1): 130 - 138.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. K. Lee, Y. S. Choi, Y. A. Park, and S. Jeong
Modulation of Oncogenic Transcription and Alternative Splicing by {beta}-Catenin and an RNA Aptamer in Colon Cancer Cells
Cancer Res., November 1, 2006; 66(21): 10560 - 10566.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Oltean, B. S. Sorg, T. Albrecht, V. I. Bonano, R. M. Brazas, M. W. Dewhirst, and M. A. Garcia-Blanco
Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity
PNAS, September 19, 2006; 103(38): 14116 - 14121.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Capra, P. G. Nuciforo, S. Confalonieri, M. Quarto, M. Bianchi, M. Nebuloni, R. Boldorini, F. Pallotti, G. Viale, M. L. Gishizky, et al.
Frequent Alterations in the Expression of Serine/Threonine Kinases in Human Cancers
Cancer Res., August 15, 2006; 66(16): 8147 - 8154.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Guillouf, I. Gallais, and F. Moreau-Gachelin
Spi-1/PU.1 Oncoprotein Affects Splicing Decisions in a Promoter Binding-dependent Manner
J. Biol. Chem., July 14, 2006; 281(28): 19145 - 19155.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. Srebrow and A. R. Kornblihtt
The connection between splicing and cancer
J. Cell Sci., July 1, 2006; 119(13): 2635 - 2641.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
T. Castrignano, R. Rizzi, I. G. Talamo, P. D. De Meo, A. Anselmo, P. Bonizzoni, and G. Pesole
ASPIC: a web resource for alternative splicing prediction and transcript isoforms characterization.
Nucleic Acids Res., July 1, 2006; 34(Web Server issue): W440 - W443.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
E. A. Newman, S. J. Muh, R. H. Hovhannisyan, C. C. Warzecha, R. B. Jones, W. L. McKeehan, and R. P. Carstens
Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays
RNA, June 1, 2006; 12(6): 1129 - 1141.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H.-R. Li, J. Wang-Rodriguez, T. M. Nair, J. M. Yeakley, Y.-S. Kwon, M. Bibikova, C. Zheng, L. Zhou, K. Zhang, T. Downs, et al.
Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens.
Cancer Res., April 15, 2006; 66(8): 4079 - 4088.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. C.K. Wong, K.C. A. Chan, A. T.C. Chan, S.-F. Leung, L. Y.S. Chan, K. C.K. Chow, and Y.M. D. Lo
Reduced Plasma RNA Integrity in Nasopharyngeal Carcinoma Patients
Clin. Cancer Res., April 15, 2006; 12(8): 2512 - 2516.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
H.-H. Chen, Y.-C. Wang, and M.-J. Fann
Identification and Characterization of the CDK12/Cyclin L1 Complex Involved in Alternative Splicing Regulation.
Mol. Cell. Biol., April 1, 2006; 26(7): 2736 - 2745.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
D. J. Law, E. M. Labut, R. D. Adams, and J. L. Merchant
An isoform of ZBP-89 predisposes the colon to colitis
Nucleic Acids Res., March 3, 2006; 34(5): 1342 - 1350.
[Abstract] [Full Text] [PDF]

Home page
 Mol Biol EvolHome page
F.-C. Chen, S.-S. Wang, C.-J. Chen, W.-H. Li, and T.-J. Chuang
Alternatively and Constitutively Spliced Exons Are Subject to Different Evolutionary Forces
Mol. Biol. Evol., March 1, 2006; 23(3): 675 - 682.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Li, M. Kato, L. Shiue, J. E. Shively, M. Ares Jr., and R.-J. Lin
Cell Type and Culture Condition-Dependent Alternative Splicing in Human Breast Cancer Cells Revealed by Splicing-Sensitive Microarrays
Cancer Res., February 15, 2006; 66(4): 1990 - 1999.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. J. Pajares, I. Zudaire, M. D. Lozano, J. Agorreta, G. Bastarrika, W. Torre, A. Remirez, R. Pio, J. J. Zulueta, and L. M. Montuenga
Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 373 - 380.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. Milani, M. Fredriksson, and A.-C. Syvanen
Detection of Alternatively Spliced Transcripts in Leukemia Cell Lines by Minisequencing on Microarrays
Clin. Chem., February 1, 2006; 52(2): 202 - 211.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Wang, B. Yan, J.-t. Guo, C. Hicks, and Y. Xu
Structural genomics analysis of alternative splicing and application to isoform structure modeling
PNAS, December 27, 2005; 102(52): 18920 - 18925.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
P L Jeffery, R E Murray, A H Yeh, J F McNamara, R P Duncan, G D Francis, A C Herington, and L K Chopin
Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines
Endocr. Relat. Cancer, December 1, 2005; 12(4): 839 - 850.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. H. Yeh, P. L. Jeffery, R. P. Duncan, A. C. Herington, and L. K. Chopin
Ghrelin and a Novel Preproghrelin Isoform Are Highly Expressed in Prostate Cancer and Ghrelin Activates Mitogen-Activated Protein Kinase in Prostate Cancer
Clin. Cancer Res., December 1, 2005; 11(23): 8295 - 8303.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Cully, J. Shiu, R. P. Piekorz, W. J. Muller, S. J. Done, and T. W. Mak
Transforming Acidic Coiled Coil 1 Promotes Transformation and Mammary Tumorigenesis
Cancer Res., November 15, 2005; 65(22): 10363 - 10370.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. Roy, Q. Xu, and C. Lee
Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms
Nucleic Acids Res., September 7, 2005; 33(16): 5026 - 5033.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Narla, A. DiFeo, S. Yao, A. Banno, E. Hod, H. L. Reeves, R. F. Qiao, O. Camacho-Vanegas, A. Levine, A. Kirschenbaum, et al.
Targeted Inhibition of the KLF6 Splice Variant, KLF6 SV1, Suppresses Prostate Cancer Cell Growth and Spread
Cancer Res., July 1, 2005; 65(13): 5761 - 5768.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.